References with SARS-CoV-2 Fusion Peptides

  1. Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
    Loyal et al., Science 2021 – PMID : 34465633
  2. Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering
    Ong et al. Computational & Structural Biotechnology Journal (2021) – PMID : 33398234
  3. CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses
    Woldemeskel et al., Clinical Trial in Journal of Clinical Investigation (2022) – PMID : 35061630

Related Products: 

Check our list of products, click and go.

Get a quote